UnknownNot applicableNCT00579956
A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis
Studying Melioidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Oxford
- Principal Investigator
- Wirongrong Chierakul, MDMahidol University
- Intervention
- Meropenem(drug)
- Enrollment
- 750 enrolled
- Eligibility
- 15 years · All sexes
- Timeline
- 2007 – 2010
Study locations (2)
- Sappasithiprasong Hospital, Ubonratchathani, Changwat Ubon Ratchathani, Thailand
- Udon Thani General Hospital, Udon Thani, Thailand
Collaborators
Mahidol University · Wellcome Trust
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00579956 on ClinicalTrials.gov